Advanced Proteome Therapeutics (TSXV:APC.H) Change In Receivables : C$0.00 Mil (TTM As of Apr. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Advanced Proteome Therapeutics Change In Receivables?

Advanced Proteome Therapeutics's change in receivables for the quarter that ended in Apr. 2023 was C$0.00 Mil. It means Advanced Proteome Therapeutics's Accounts Receivable stayed the same from Jan. 2023 to Apr. 2023 .

Advanced Proteome Therapeutics's change in receivables for the fiscal year that ended in Jul. 2022 was C$0.00 Mil. It means Advanced Proteome Therapeutics's Accounts Receivable stayed the same from Jul. 2021 to Jul. 2022 .

Advanced Proteome Therapeutics's Accounts Receivable for the quarter that ended in Apr. 2023 was C$0.02 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Advanced Proteome Therapeutics's liquidation value for the three months ended in Apr. 2023 was C$-0.05 Mil.

Advanced Proteome Therapeutics Change In Receivables Historical Data

The historical data trend for Advanced Proteome Therapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Change In Receivables Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Change In Receivables

Get a 7-Day Free Trial

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Advanced Proteome Therapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Apr. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Advanced Proteome Therapeutics (TSXV:APC.H) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Advanced Proteome Therapeutics's Days Sales Outstanding for the quarter that ended in Apr. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.018	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Advanced Proteome Therapeutics's accounts receivable are only considered to be worth 75% of book value:

Advanced Proteome Therapeutics's liquidation value for the quarter that ended in Apr. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.053	-	0.113	+	0.75 * 0.018	+	0.5 * 0
=	-0.05

Advanced Proteome Therapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (TSXV:APC.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (TSXV:APC.H) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

0E81:Germany

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (TSXV:APC.H) Headlines

No Headlines